The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wang Lai since 2021.
This trader's CIK number is 1852291.
At the time of last reporting, Wang Lai was the Global Head of R&D of Beone Medicines Ltd.. (stock ticker symbol ONC).
Also see all insider trading activities at Beone Medicines Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ONC | 0 | $0 | 14,077 | $3,853,944 | 0 | $0 |
| 2024 | ONC | 0 | $0 | 8,405 | $1,640,605 | 0 | $0 |
| 2023 | ONC | 0 | $0 | 2,895 | $560,999 | 0 | $0 |
| 2022 | ONC | 0 | $0 | 2,286 | $344,697 | 1,233,947 | $3,566,106 |
| 2021 | ONC | 0 | $0 | 802 | $265,583 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-29 | ONC | Sale | 4,041 | 303.03 | 1,224,540 |
| 2025-07-30 | ONC | Sale | 259 | 305.00 | 78,995 |
| 2025-07-18 | ONC | Sale | 700 | 300.00 | 210,000 |
| 2025-06-23 | ONC | Sale | 1,028 | 260.00 | 267,280 |
| 2025-06-17 | ONC | Sale | 470 | 251.37 | 118,141 |
| 2025-06-16 | ONC | Sale | 1,177 | 266.40 | 313,557 |
| 2025-06-06 | ONC | Sale | 1,402 | 252.77 | 354,386 |
| 2025-02-21 | BGNE | Sale | 5,000 | 257.41 | 1,287,045 |
| 2024-09-27 | BGNE | Sale | 5,000 | 220.35 | 1,101,775 |
| 2024-06-24 | BGNE | Sale | 1,064 | 160.45 | 170,718 |
| 2024-06-17 | BGNE | Sale | 1,500 | 159.21 | 238,808 |
| 2024-06-18 | BGNE | Sale | 841 | 153.75 | 129,304 |
| 2023-06-26 | BGNE | Sale | 1,108 | 182.53 | 202,245 |
| 2023-06-20 | BGNE | Sale | 1,325 | 192.42 | 254,955 |
| 2023-06-07 | BGNE | Sale | 462 | 224.67 | 103,799 |
| 2022-06-27 | BGNE | Sale | 458 | 177.32 | 81,214 |
| 2022-06-21 | BGNE | Sale | 723 | 149.01 | 107,733 |
| 2022-06-17 | BGNE | Sale | 445 | 139.40 | 62,033 |
| 2022-06-06 | BGNE | Sale | 660 | 142.00 | 93,717 |
| 2022-05-17 | BGNE | Option Ex | 1,233,947 | 2.89 | 3,566,106 |
| 2021-06-18 | BGNE | Sale | 802 | 331.15 | 265,583 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wang Lai (Global Head of R&D of Beone Medicines Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.